학술논문
Cemp, A Mitoxantrone Containing Combination, in the Treatment of Intermediate and High Grade...
Document Type
Article
Author
Source
Subject
*COMBINATION drug therapy
*HODGKIN'S disease
*DRUG tolerance
*DRUG efficacy
*
*
*
Language
ISSN
1042-8194
Abstract
Assesses the therapeutic efficacy and tolerability of a chemotherapy cyclophosphamide, etoposide, mitoxantrone and predinisone (CEMP) in adult and elderly patients with advanced intermediate and high-grade non-Hodgkin's lymphoma. Patient characteristics; Percent of patients who achieved complete remission; Response survival rate; Disease-free survival percentage.